Azmi Nabulsi
2023
In 2023, Azmi Nabulsi earned a total compensation of $2M as Chief Operating Officer at Phathom Pharmaceuticals, a 26% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $320,022 |
|---|---|
| Option Awards | $383,325 |
| Salary | $552,000 |
| Stock Awards | $763,691 |
| Other | $16,875 |
| Total | $2,035,913 |
Nabulsi received $763.7K in stock awards, accounting for 38% of the total pay in 2023.
Nabulsi also received $320K in non-equity incentive plan, $383.3K in option awards, $552K in salary and $16.9K in other compensation.
Rankings
In 2023, Azmi Nabulsi's compensation ranked 504th out of 2,785 executives tracked by ExecPay. In other words, Nabulsi earned more than 81.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 504 out of 2,785 | 82nd |
Division Manufacturing | 290 out of 1,525 | 81st |
Major group Chemicals And Allied Products | 204 out of 864 | 76th |
Industry group Drugs | 201 out of 827 | 76th |
Industry Pharmaceutical Preparations | 126 out of 592 | 79th |
Source: SEC filing on April 12, 2024.
Nabulsi's colleagues
We found two more compensation records of executives who worked with Azmi Nabulsi at Phathom Pharmaceuticals in 2023.
News
Phathom Pharmaceuticals CEO Terrie Curran's 2023 pay falls 32% to $3.4M
April 12, 2024
Phathom Pharmaceuticals CEO Terrie Curran's 2022 pay slips 20% to $5M
April 13, 2023
Phathom Pharmaceuticals CEO Terrie Curran's 2020 pay jumps 34% to $4.6M
April 6, 2021
Phathom Pharmaceuticals CEO Terrie Curran receives $3.5M in 2019
April 8, 2020